Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed …,

BOSTON, Oct. 29, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., (Nasdaq: TALS), a late-clinical stage cell therapy company developing …, BOSTON, Oct. 29, 2021 (GLOBE NEWSWIRE) — Talaris Therapeutics, Inc., (Nasdaq: TALS), a late-clinical stage cell therapy company developing …, Read More

Scroll to Top